Ontruzant

Active Ingredient(s): Trastuzumab-dttb
FDA Approved: * January 18, 2019
Pharm Company: * SAMSUNG BIOEPIS CO LTD
Category: Cancer

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.[3][4][5][6] It is specifically used for cancer that is HER2 receptor positive.[3] It may be used by itself or together with other chemotherapy medication.[3] Trastuzumab is given by slow injection into a vein and injection just under the skin.[3]&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ontruzant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0006-5033
Labeler:
Merck Sharp & Dohme Corp.
OntruzantOntruzant Intravenous Kit
NDC: 0006-5034
Labeler:
Merck Sharp & Dohme Corp.

Related Brands

Drugs with the same active ingredients